Table 1.
Clinical characteristics of the groups Gr 1-MNA and Gr NO-1-MNA at Phase 0.
| Parameters | Gr 1-MNA n = 25 M ± SD 95% CI |
Gr NO-1-MNA n = 25 M ± SD 95% CI |
p-Value | |
|---|---|---|---|---|
| Age | 47.40 ± 9.73 43.38–51.42 |
49.60 ± 10.55 45.24–53.96 |
0.447 | |
| Median | 49 | 50 | ||
| Sex | Female | 17 (0.68) | 17 (0.68) | 1.000 |
| Male | 8 (0.32) | 8 (0.32) | ||
| BMI (kg/m 2 ) | 26.88 ± 4.69 24.94–28.82 |
27.17 ± 4.92 25.14–29.20 |
0.834 | |
| Median | 25.97 | 26.42 | ||
| Heart rate at rest in Phase 0 | 72.40 ± 11.74 67.55–77.25 |
78.64 ± 1.32 78.10–79.18 |
0.352 | |
| Median | 76 | 79 | ||
| Oxygen saturation at rest in Phase 0 | 97.28 ± 2.03 96.44–98.12 |
96.96 ± 4.71 95.02–98.90 |
0.522 | |
| Median | 98 | 98 | ||
| Distance in 6 min walk test in Phase 0 | 515.8 ± 63 512.24–519.36 |
519.2 ± 69 490.72–547.68 |
0.850 | |
| Median | 516 | 504 | ||
| Fatigue assessment according to Fatigue Severity Score in Phase 0 | 4.28 ± 1.38 3.71–4.85 |
4.53 ± 1.16 4.05–5.01 |
0.490 | |
| Median | 4.44 | 4.54 | ||
| Dyspnoea on the Borg Scale at rest in Phase 0 | 0.128 | |||
| 0 | 8 (0.32) | 7 (0.28) | ||
| 1 | 3 (0.12) | 2 (0.08) | ||
| 2 | 9 (0.36) | 3 (0.12) | ||
| 3 | 2 (0.08) | 9 (0.36) | ||
| 4 | 2 (0.08) | 2 (0.08) | ||
| 5 | 1 (0.04) | 2 (0.08) | ||
M—mean; SD—standard deviation; 95%CI—95% confidence interval; BMI—body mass index, derived from the mass (weight) and height of a person. The BMI is defined as the body mass divided by the square of the body height, and is expressed in units of kg/m2, resulting from mass in kilograms and height in meters. Gr NO-1-MNA—patients without supplementation; Gr 1-MNA—patients with MNA-1 supplementation; p—statistical significance. Bolds means highlight data.